Unlike SARS-CoV-2 infection, where the formation of neutralising antibody that can interact with circulating variants is common and occurs within ∼10 days from the onset of symptoms, broadly neutralising antibodies (bNAbs) against the far more diverse HIV-1 Env are inefficiently induced by natural infection. The gene discussed is ERVW-1; the disease is infection.